Celecoxib ’s Cardiovascular Safety
The selective cyclooxygenase 2 (COX-2) inhibitor celecoxib is no more likely than 2 nonsteroidal anti-inflammatory drugs (NSAIDs) to cause cardiovascular death, nonfatal myocardial infarction, or stroke in patients with coronary disease or other cardiovascular risks.
Source: JAMA - Category: Journals (General) Source Type: research
More News: Cardiology | Cardiovascular | Celebrex | General Medicine | Heart | Heart Attack | Stroke